Rick Scalzo
Director of Finance/CFO at DYNE THERAPEUTICS, INC.
Net worth: 3 M $ as of 2024-04-29
Profile
Rick Scalzo's current job is Senior Vice President-Finance & Administration at Dyne Therapeutics, Inc. His former jobs include being a Controller at Astellas Institute for Regenerative Medicine in 2014, Chief Accounting Officer at Kaleido Biosciences, Inc. in 2019, and Controller at X4 Pharmaceuticals, Inc. from 2016 to 2018.
He completed his undergraduate degree at Boston College in 2008 and earned an MBA from the University of Massachusetts in 2016.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DYNE THERAPEUTICS INC
0.14% | 2024-05-15 | 116,695 ( 0.14% ) | 3 M $ | 2024-04-29 |
Rick Scalzo active positions
| Companies | Position | Start |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Director of Finance/CFO | 2020-06-30 |
Former positions of Rick Scalzo
| Companies | Position | End |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 2019-11-28 |
| X4 PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2018-07-31 |
| OCATA THERAPEUTICS INC | Comptroller/Controller/Auditor | 2014-08-31 |
Training of Rick Scalzo
| University of Massachusetts | Masters Business Admin |
| Boston College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| DYNE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
- Stock Market
- Insiders
- Rick Scalzo
